gabionline.net

Sun Pharma Completes $11.75B Financing Syndication for Organon Acquisition

Sun Pharmaceutical logoSun Pharmaceutical
Sig5.90Sen+4.60Env0.00Soc+1.10Gov+1.20
Organon logoOrganon
Sig8.05Sen+1.80Env0.00Soc0.00Gov0.00

Sun Pharma secured $11.75bn in syndicated financing for its all-cash Organon acquisition, funding the remainder from internal cash. Eight more lenders joined by 30 June, bringing the total to 11, with SBI the only Indian bank. Chairman Dilip Shanghvi signed the deal in April 2026, targeting about $12.4bn in combined annual revenue and a boost to Sun’s global biosimilars footprint.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro